logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Andrew J. Wagner

Dana-Farber Cancer Institute
H指数:63
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial

维米塞替尼治疗腱鞘巨细胞瘤患者的多中心、开放标签、II期临床试验

Cancer
IF5.1
2026-08-300
OAAI
Silvia Stacchiotti MD; Jean-Yves Blay MD, PhD; Piotr Rutkowski MD, PhD; Hans Gelderblom MD, PhD; Alejandro Falcón MD, PhD; Axel Le Cesne MD; Jayesh Desai MBBS, FRACP; Emanuela Palmerini MD, PhD; César Serrano MD, PhD; Kristen N. Ganjoo MD; Gina Z. D’Amato MD; Christopher W. Ryan MD; Breelyn A. Wilky MD; Virginia Ferraresi MD; Ramy Saleh MD, MSc, FRCPC; Vinod Ravi MD, MS, MBA; Albiruni Abdul Razak MB BCh, BM BCh; Antonio Casado Herráez MD, PhD; Mahbubl Ahmed MBBS, PhD; Nicholas M. Bernthal MD; Michiel van de Sande MD, PhD; Mehdi Brahmi MD, PhD; Bartlomiej Szostakowski MD, PhD; Jasmine Sen MS; Nicholas A. Zeringo PhD; Brooke Harrow PhD; Supraja Narasimhan PhD; Amanda Saunders DO; Maitreyi G. Sharma MD; Matthew L. Sherman MD; Andrew J. Wagner MD, PhD; William D. Tap MD
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study

培非达artinib在腱鞘巨细胞瘤患者中的长期有效性与安全性：ENLIVEN研究的最终结果

ONCOLOGIST
IF4.2
2025-07-014
PRE
Wagner, Andrew J.; Tap, William D.; Bauer, Sebastian; Blay, Jean-Yves; Desai, Jayesh; Gelderblom, Hans; Palmerini, Emanuela; Ryan, Christopher W.; Peterfy, Charles; Healey, John H.; van de Sande, Michiel; Qian, Meng; Shuster, Dale E.; Rajper, Abdul; Ye, Xin; Tecson, Kristen; Wooddell, Margaret J.; Stacchiotti, Silvia
A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib
CANCER
IF5.1
2024-11-121
OAAI
Desai, Jayesh; Wagner, Andrew J.; Carrasco Garcia, Irene; Cesari, Marilena; Gordon, Michael; Lin, Chia-Chi; Papai, Zsuzsanna; Ryan, Christopher W.; Tap, William D.; Trent, Jonathan C.; Gelderblom, Hans; Grimison, Peter; Lopez Pousa, Antonio; Van Tine, Brian A.; Rubinacci, Maria; Dai, Dong; Rajper, Abdul Waheed; Tecson, Kristen; Wooddell, Margaret; Stacchiotti, Silvia
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

pembrolizumab，放射治疗和手术与放射治疗和手术治疗肢体III期软组织肉瘤的安全性和有效性 (SU2C-SARC032): 一项开放标签，随机临床试验

LANCET
IF88.5
2024-11-010
PRE
Mowery, Yvonne M.; Ballman, Karla, V; Hong, Angela M.; Schuetze, Scott M.; Wagner, Andrew J.; Monga, Varun; Heise, Rachel S.; Attia, Steven; Choy, Edwin; Burgess, Melissa A.; Bae, Susie; Pryor, David, I; Tine, Brian A. Van; Tinoco, Gabriel; Chmielowski, Bartosz; Freeman, Carolyn; Gronchi, Alessandro; Meyer, Christian F.; Dickson, Mark A.; Hartner, Lee; Davis, Lara E.; Powers, Benjamin C.; Moding, Everett J.; Weinhold, Kent J.; van de Rijn, Matt; Briqman, Brian E.; Riedel, Richard F.; Kirsch, David G.
Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial

更新后的vimelstinib在腱鞘巨细胞瘤（TGCT）患者中的疗效与安全性：MOTION III期试验的一年随访结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Gelderblom, H.; Bhadri, V. A.; Stacchiotti, S.; Bauer, S.; Wagner, A. J.; van de Sande, M.; Bernthal, N. M.; Pousa, A. Lopez; Razak, A. R. Abdul; Italiano, A.; Ahmed, M.; Le Cesne, A.; Tait, C.; Saunders, A.; Harrow, B.; Sharma, M. G.; Ruiz-Soto, R.; Sherman, M. L.; Blay, J-Y.; Tap, W. D.
Safety, efficacy, and patient-reported outcomes (PROs) with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received prior antiecolony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study

安全性、有效性和患者报告结局（PROs）在先前接受抗集落刺激因子1（CSF1）治疗的患者（pts）中的维姆斯替尼布（vimseltinib）治疗结果：正在进行中的II期研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
D'Amato, G.; Wagner, A. J.; Ganjoo, K. N.; Stacchiotti, S.; Gelderblom, H.; Ryan, C. W.; Palmerini, E.; Ravi, V.; Saleh, R.; Le Cesne, A.; Bernthal, N. M.; van de Sande, M.; Narasimhan, S.; Harrow, B.; Saunders, A.; Ruiz-Soto, R.; Sherman, M. L.; Tap, W. D.
Low-grade fi bromyxoid sarcoma and sclerosing epithelioid fi brosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group
ESMO OPEN
IF8.3
2024-09-010
OAAI
Giani, C.; Denu, R. A.; Ljevar, S.; Gronchi, A.; Napolitano, A.; Rosenbaum, E.; Salawu, A.; Bajpai, J.; Connolly, E. A.; Lee, A. T. J.; Trent, J. C.; Kosela-Paterczyk, H.; Li, Z. Chia-Chen; Ogura, K.; Palmerini, E.; Baldi, G. G.; Brunello, A.; Campos, F.; Cicala, C. M.; Maki, R. G.; Wagner, A. J.; Andelkovic, V.; Loong, H. H.; Wong, D. D.; Jones, R. L.; Tap, W. D.; Taverna, S. M.; Lazar, A. J.; Demicco, E. G.; Hong, A.; Bovee, J. V. M. G.; Tos, A. P. Dei; Fletcher, C. D. M.; Baumhoer, D.; Sbaraglia, M.; Schaefer, I. M.; Miceli, R.; Stacchiotti, S.
Safety and efficacy with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received no prior antiecolony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study

维美替尼在未接受过集落刺激因子1（CSF1）治疗的原发性腱鞘巨细胞瘤（TGCT）患者中的安全性与有效性：正在进行中的II期研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Serrano, C.; Blay, J-Y.; Rutkowski, P.; Gelderblom, H.; Stacchiotti, S.; Falcon Gonzalez, A.; Desai, J.; Le Cesne, A.; Ferraresi, V.; Palmerini, E.; Wilky, B. A.; Wagner, A. J.; Bernthal, N. M.; van de Sande, M.; Narasimhan, S.; Harrow, B.; Sharma, M. G.; Ruiz-Soto, R.; Sherman, M. L.; Tap, W. D.
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, doubleblind, placebo-controlled, phase 3 trial
LANCET
IF88.5
2024-06-013
PRE
Gelderblom, Hans; Bhadri, Vivek; Stacchiotti, Silvia; Bauer, Sebastian; Wagner, Andrew J.; van de Sande, Michiel; Bernthal, Nicholas M.; Pousa, Antonio Lopez; Razak, Albiruni Abdul; Italiano, Antoine; Ahmed, Mahbubl; Le Cesne, Axel; Tinoco, Gabriel; Boye, Kjetil; Martin-Broto, Javier; Palmerini, Emanuela; Tafuto, Salvatore; Pratap, Sarah; Powers, Benjamin C.; Reichardt, Peter; Herraez, Antonio Casado; Rutkowski, Piotr; Tait, Christopher; Zarins, Fiona; Harrow, Brooke; Sharma, Maitreyi G.; Ruiz-Soto, Rodrigo; Sherman, Matthew L.; Blay, Jean-Yves; Tap, William D.
Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas
ANNALS OF ONCOLOGY
IF65.4
2023-10-012
PRE
Jones, R. L.; Sanfilippo, R.; Schuetze, S. M.; Sebio, A.; Alvarez, R. M.; Bui, N.; Wagner, A. J.; Chawla, S. P.; Chen, T. W-W.; Pink, D.; Le Cesne, A.; Italiano, A.; Vincenzi, B.; Kiladze, I. Z.; Patel, S.; Bryce, R.; Xu, F.; Doebele, R. C.; Schwartz, G.; Gounder, M.

研究方向

暂未获取到该数据
G
George D. Demetri
H 指数:114论文数:637被引数:6.3万
H
Hans Gelderblom
H 指数:107论文数:1,321被引数:5.3万
S
Silvia Stacchiotti
H 指数:86论文数:677被引数:2.5万
W
William D. Tap
H 指数:74论文数:921被引数:2.5万
J
Jean‐Yves Blay
H 指数:158论文数:2,395被引数:9.5万
S
Suzanne George
H 指数:74论文数:622被引数:2.0万
R
Robin L. Jones
H 指数:92论文数:1,576被引数:3.6万
C
Chandrajit P. Raut
H 指数:86论文数:468被引数:5.3万
A
Alessandro Gronchi
H 指数:114论文数:1,094被引数:4.3万
J
Jason L. Hornick
H 指数:108论文数:1,079被引数:4.3万